SCHEMBL5707773

SCHEMBL5707773

COc1cc(OC)c2c(c1)O/C(=C\c1ccc(C(C)C)cc1)C2=O

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.72
MAOB P27338 8/20 0.55
HDAC3 O15379 2/20 0.51
HDAC4 P56524 2/20 0.51
HDAC1 Q13547 2/20 0.51
HDAC7 Q8WUI4 2/20 0.51
HDAC2 Q92769 2/20 0.51
HDAC10 Q969S8 2/20 0.51
HDAC11 Q96DB2 2/20 0.51
HDAC8 Q9BY41 2/20 0.51
HDAC6 Q9UBN7 2/20 0.51
HDAC9 Q9UKV0 2/20 0.51
HDAC5 Q9UQL6 2/20 0.51
ACHE P22303 1/20 0.46
KIT P10721 1/20 0.46
PNLIP P16233 1/20 0.44
STK17B O94768 2/20 0.44
PTGS2 P35354 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5707806 0.86 ABCG2 (0.77) ABCG2MAOBHDAC3HDAC4HDAC1
SCHEMBL5707740 0.85 ABCG2 (0.76) ABCG2MAOBHDAC3HDAC4HDAC1
SCHEMBL5707776 0.85 ABCG2 (0.75) ABCG2MAOBHDAC3HDAC4HDAC1
SCHEMBL5707781 0.85 ABCG2 (0.75) ABCG2MAOBHDAC3HDAC4HDAC1
4,6,3',4'-Tetramethoxyaurone SCHEMBL30804715 0.84 ABCG2 (1.00) ABCG2MAOBHDAC3HDAC4HDAC1
SCHEMBL5707789 0.83 ABCG2 (0.72) ABCG2MAOBHDAC3HDAC4HDAC1
SCHEMBL5707783 0.83 ABCG2 (0.72) ABCG2MAOBHDAC3HDAC4HDAC1
SCHEMBL5707834 0.82 ABCG2 (0.71) ABCG2MAOBHDAC3HDAC4HDAC1
SCHEMBL5707767 0.82 ABCG2 (0.71) ABCG2MAOBHDAC3HDAC4HDAC1
SCHEMBL5707778 0.82 ABCG2 (0.71) ABCG2MAOBHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060228313-A1 Method of cosmetic depigmentation care by applying at least one aurone COLETICA (FR) 2006-10-12 US claimed
EP-1709964-A2 A method of cosmetic depigmentation care by applying at least one aurone ENGELHARD LYON (FR) 2006-10-11 EP claimed
US-20060228313-A1 Method of cosmetic depigmentation care by applying at least one aurone COLETICA (FR) 2006-10-12 US disclosed
EP-1709964-A2 A method of cosmetic depigmentation care by applying at least one aurone ENGELHARD LYON (FR) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060228313-A1 Method of cosmetic depigmentation care by applying at least one aurone TYR, MITF, MC1R ABCG2 1836/4885MAOB 27/4885HDAC3 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.